Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?

dc.contributor.authorWish, Jay B.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-03-22T11:53:38Z
dc.date.available2024-03-22T11:53:38Z
dc.date.issued2023-10-06
dc.eprint.versionFinal published version
dc.identifier.citationWish JB. Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?. Kidney Int Rep. 2023;8(11):2194-2197. Published 2023 Oct 6. doi:10.1016/j.ekir.2023.10.001
dc.identifier.urihttps://hdl.handle.net/1805/39419
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.ekir.2023.10.001
dc.relation.journalKidney International Reports
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectHyperphosphatemia
dc.subjectDialysis
dc.subjectChronic kidney disease
dc.subjectBone disorder
dc.titleTenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
main.pdf
Size:
165.1 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: